Asthma Clinical Trial
Official title:
Improving the Quality of Private Sector Health Care in West Bengal
Verified date | June 2017 |
Source | Abdul Latif Jameel Poverty Action Lab |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The rural healthcare market in much of the developing world is composed largely of informal
private providers. These private providers often have little to no certifiable medical
training. Recent studies in India using medical vignettes (or hypothetical medical
situations) to measure clinical competence and direct observations of doctor-patient
interactions to measure clinical practice highlight the poor quality of care that most
patients receive—a problem that is clearly relevant beyond India and affects most low-income
countries worldwide. For instance:
1. In rural India, standardized patients presenting with chest pain and (on further
questioning) radiating pain in the arm are (correctly) diagnosed with a heart attack in
less than 25 percent of cases.
2. Across 8 low and middle-income countries, health care providers completed the four
necessary vital statistics for new patients in less than 4 percent of interactions:
health care providers in the public sectors of many developing countries routinely
spend less than 1 minute per patient.
To address these deplorably low standards in both medical knowledge and practice, the Liver
Foundation in Kolkata has been working with private rural health care providers through
capacity building activities to improve quality in the private sector. The program consists
of multiple-week training to private rural health care providers on the basis of a
well-developed curriculum in the district of Birbhum, West Bengal.
This study aims to assess the impact of this training program using a randomized evaluation,
in which providers are randomly assigned to the treatment, i.e. the Liver Foundation's
training program, or the control, i.e. no such training. As an independent outside
evaluation team, we will run a baseline survey for all providers (through a third party data
collection agency), monitor the application of and compliance in the Liver Foundation's
training intervention, and conduct a final endline study. By comparing the treatment and
control groups on a variety of measures developed to capture competence in provider
knowledge and practice, we can rigorously assess whether such a training program for
informal rural health care providers is an effective means of improving provider medical
knowledge and practice in the short run. It is worth noting that this study will not be able
to capture long run effects , such as price or location changes, on health care for the
rural poor.
Status | Completed |
Enrollment | 304 |
Est. completion date | May 2015 |
Est. primary completion date | May 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 62 Years |
Eligibility |
Inclusion Criteria: - must be a private rural healthcare practitioner in West Bengal Exclusion Criteria: - cannot live outside of three specified districts of West Bengal |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Abdul Latif Jameel Poverty Action Lab | Liver Foundation, West Bengal, National Rural Health Mission, Government of West Bengal, India, World Bank |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical Practice | Clinical Practice will be assessed in two ways. First, we will send Standardized Patients, or trained professionals who present with a pre-developed set of symptoms (of one of the three conditions specified) to a provider without the provider's knowledge that he/she is acting. Second, the evaluating team will sit in the providers' clinics after the completion of the intervention, observing provider-patient interactions for a full day. Information will be obtained for each provider-patient interaction on (a) consultation length, (b) history taking, (c) examinations performed, (d) information given to the patient, (e) medicines dispensed/prescribed and (f) prices charged. | Endline (3-4 months after completion of intervention) | |
Secondary | Clinical Competence | Clinical competence will be assessed through the use of medical vignettes, which have been developed and used in a number of countries. In these medical vignettes, providers are presented with a series of symptoms related to a particular disease or medical condition and are evaluated on their ability to diagnose correctly and make the proper recommendations. The impact of the program in terms of clinical competence will be computed using a difference-in-difference estimator, which is the gain in the treatment group minus the gain in the control group in the completion of checklist items and diagnosis rates for the cases considered. | Endline (3-4 months after completion of intervention) | |
Secondary | Clinical prices and caseload | Clinical prices, or the consultation fees charged to patients, and caseload, or the number of patients a health practitioner sees per day, will be assessed using both direct observation and the standardized patients. In both cases, prices will be noted and recorded to assess the impact of the treatment. | Endline (3-4 months after completion of intervention) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|